Unmet Needs and Future Perspectives on the treatment of R/R MM

Experts provide advice for patients and caregivers with relapsed/refractory multiple myeloma considering talquetamab or another bispecific, while all faculty will discuss unmet needs and future perspectives in the treatment of relapsed/refractory multiple myeloma.

EP: 1.Overview of Relapsed/Refractory Multiple Myeloma: Diagnosis, Treatment Options, Unmeet Needs

EP: 2.MonumenTAL-1: Long Term Follow up Efficacy

EP: 3.MonumenTAL-1: Safety and AEs

EP: 4.Managing GPRC5D Therapy: Unique AE Challenges and Patient Preparation

EP: 5.Administering GPRC5D therapy: Dosing and Monitoring for CRS & ICANS

EP: 6.Managing toxicities of BCMA_targeting Bispecfics

EP: 7.Management of Oral Toxcities associated with GPRC5D Bispecifics Nail

EP: 8.Management of Skin and Nail AEs: Advice to Patients and Caregivers

EP: 9.Prophylactic Strategies and Advice for Managing AEs in Bispecific Therapies

Now Viewing

EP: 10.Unmet Needs and Future Perspectives on the treatment of R/R MM

Video content above is prompted by the following:

• What advice do you have for patients and caregivers with relapsed/refractory multiple myeloma (R/R MM), particularly those who are considering talquetamab treatment or another bispecific?
• Please share some unmet needs and future perspectives on the treatment of R/R MM.

Recent Videos